Previously submitted to: JMIR Research Protocols (no longer under consideration since Jan 12, 2022)
Date Submitted: Jun 17, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Prevalence of Suicidal Ideation in Patients with Covid-19 in the World: Systematic Review and Meta-Analysis Protocol
ABSTRACT
Background:
The pandemic of Covid-19 started in China in late 2019 and has spread rapidly around the world. Psychological problems such as suicide ideation of Covid-19 is one of the main consequences of this pandemic, which needs more attention
Objective:
This study aims to determine a comprehensive estimate of the prevalence of suicidal ideation in patients with Covid-19 in the world.
Methods:
The review study will be based on the following databases: databases of Web of Sciences, Mediline/Pubmed, Proquest, Scopus, Science Direct. This study is limited to original studies published in peer-reviewed journals in English.
Results:
The quality assessment of studies will be done using the Joanna Briggs Institute’s (JBI) critical appraisal checklist for reporting the prevalence data. The overall synthetized measurement will be presented as Prevalence with 95% confidence intervals.
Conclusions:
This review and meta-analyses will be the first study that explores the prevalence of suicide ideation related to Covid-19. Summarizing the related data can create an image of the dimensions of the problem across the world and provide plans to prevent that.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.